# Determination of the Role of Microarray for Prognosis and Prediction to Chemotherapy Sensitivity in Patients With Operable, Locally Advanced and Metastatic Oesophageal Cancer

> **NCT00220077** · NA · UNKNOWN · sponsor: **Royal Marsden NHS Foundation Trust** · enrollment: 400 (estimated)

## Conditions studied

- Oesophageal Cancer

## Interventions

- **PROCEDURE:** Endoscopy

## Key facts

- **NCT ID:** NCT00220077
- **Lead sponsor:** Royal Marsden NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2002-06
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2015-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00220077

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00220077, "Determination of the Role of Microarray for Prognosis and Prediction to Chemotherapy Sensitivity in Patients With Operable, Locally Advanced and Metastatic Oesophageal Cancer". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00220077. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*